Cambridge Cognition Holdings Plc (LON:COG – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 34 ($0.45) and last traded at GBX 34.29 ($0.46), with a volume of 40612 shares changing hands. The stock had previously closed at GBX 37 ($0.49).
Cambridge Cognition Price Performance
The business’s 50 day moving average price is GBX 42.49 and its 200-day moving average price is GBX 45.29. The company has a quick ratio of 0.96, a current ratio of 0.65 and a debt-to-equity ratio of 92.53. The company has a market cap of £14.38 million, a PE ratio of -850.00 and a beta of 0.72.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Featured Stories
- Five stocks we like better than Cambridge Cognition
- Why Are Stock Sectors Important to Successful Investing?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What Are Dividend Challengers?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- P/E Ratio Calculation: How to Assess Stocks
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.